Natural Capsules Limited

NATCAPSUQ6

INE936B01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 16/07/2024 BST			5-day change	1st Jan Change
317.6 ^INR	-0.22%		-2.62%	-11.72%

05-21	Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
05-21	Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Natural Capsules Limited Announces Executive Changes

January 31, 2017 at 01:06 pm

Natural Capsules Limited announced that at its board meeting held on January 31, 2017, Mr. Skandan. P. Jain, qualified company secretary is appointed assistant company secretary and compliance officer of the company in place of Mr. D R Anand with effect from January 31, 2017.

Latest news about Natural Capsules Limited

Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-21	CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-21	CI
Natural Capsules Begins Production in First High-Speed HPMC Line	03-19	MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23	CI
Natural Capsules Raises INR750 Million from Somerset Indus Capital Partners	22/06/23	MT
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26/05/23	CI
Natural Capsules Limited Recommends Dividend	26/05/23	CI
Natural Biogenex Private Limited announced that it expects to receive INR 750.000038 million in funding from Natural Capsules Limited, Somerset Indus Capital Partners	21/04/23	CI
Natural Capsules Unit Gets INR 6.3 Million Investment	07/03/23	MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/08/22	CI
Natural Capsules Approves Resignation of Mr. Anjan Kumar as Independent Director	10/08/22	CI
Natural Capsules Sees Surge in Fiscal Q4 Consolidated Net Profit	11/05/22	MT
Natural Capsules' Consolidated Net Profit Soars in Fiscal Q4	10/05/22	MT
Natural Capsules Names New CFO	10/05/22	MT
Natural Capsules Limited Announces Chief Financial Officer Changes	10/05/22	CI
Natural Capsules Limited Recommends Dividend	10/05/22	CI
Natural Capsules Limited Recommends Dividend	09/05/22	CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	09/05/22	CI
Natural Capsules Limited Reports Earnings Results for the Full Year Ended March 31, 2022	09/05/22	CI
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	08/02/22	CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	30/10/21	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	07/08/21	CI

Chart Natural Capsules Limited

Duration

Period

More charts

Company Profile

Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in the manufacturing of vegetarian capsules. The Company's product portfolio includes capsules and steroidal active pharmaceutical ingredients (APIs). Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. The Company exports its products to over 30 countries. It has two manufacturing facilities that are located in Bengaluru and Puducherry. It has a production capacity of around five million capsules per machine per day.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NATURAL CAPSULES LIMITED	-11.72%	35.52M
ELI LILLY AND COMPANY	+61.53%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.66%	359B
MERCK & CO., INC.	+15.06%	325B
ABBVIE INC.	+9.18%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.67%	177B
PFIZER, INC.	+2.47%	165B